U.S. Patient with Advanced Lung Cancer Stabilized by Novel Immunotherapy Treatment in China

2026-03-07 - 05:36

SHANGHAI, March 7, 2026 /PRNewswire/ — Jiahui International Cancer Center (JICC) has stabilized a U.S. patient with advanced non‐small cell lung cancer (NSCLC) and Parkinson’s disease using ivonescimab, a novel immunotherapy currently available only in China. Dr. Xuan Linli, Chief of Medical Oncology at Jiahui International Cancer Center, stands on the patient’s right. The patient’s